These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


577 related items for PubMed ID: 16569550

  • 1. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [Abstract] [Full Text] [Related]

  • 2. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF.
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [Abstract] [Full Text] [Related]

  • 3. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP, Ward MR.
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [Abstract] [Full Text] [Related]

  • 4. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M, Darpö B, Ostergren J, Rosenqvist M.
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [Abstract] [Full Text] [Related]

  • 5. Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation.
    Kosior DA, Wozakowska-Kapłon B, Jasik M, Kiliszek M, Rabczenko D, Opolski G.
    Kardiol Pol; 2005 Dec; 63(6):585-92; discussion 593-4. PubMed ID: 16380855
    [Abstract] [Full Text] [Related]

  • 6. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 7. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.
    N Engl J Med; 2000 Mar 30; 342(13):913-20. PubMed ID: 10738049
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D, Opolski G, Torbicki A.
    Med Sci Monit; 2001 Mar 30; 7(1):68-73. PubMed ID: 11208496
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
    Jong GP, Chang MH, Chang TC, Chou P, Fu CY, Tien LY, Chen CY, Ma TC.
    Chin Med J (Engl); 2006 Dec 20; 119(24):2030-5. PubMed ID: 17199952
    [Abstract] [Full Text] [Related]

  • 10. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F, Huang CX, Jiang H, Yang B, Guo WL, Chen YX, Jin CR, Liu ZM.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):121-3. PubMed ID: 16620720
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A.
    Orv Hetil; 2004 May 09; 145(19):1001-6. PubMed ID: 15181735
    [Abstract] [Full Text] [Related]

  • 12. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A, Lehmann G, Ndrepepa G, Schreieck J, Alt EU, Schömig A, Schmitt C.
    Eur Heart J; 2001 Aug 09; 22(16):1504-10. PubMed ID: 11482924
    [Abstract] [Full Text] [Related]

  • 13. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng CK, Schwarz C, Lehner E, Strasser U, Lassnig E, Lamm G, Eber B, Study of Prevention of Postoperative Atrial Fibrillation.
    Am Heart J; 2004 Apr 09; 147(4):636-43. PubMed ID: 15077078
    [Abstract] [Full Text] [Related]

  • 14. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
    Lee JK, Klein GJ, Krahn AD, Yee R, Zarnke K, Simpson C, Skanes A, Spindler B.
    Am Heart J; 2000 Dec 09; 140(6):871-7. PubMed ID: 11099990
    [Abstract] [Full Text] [Related]

  • 15. Amiodarone versus sotalol for atrial fibrillation.
    Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Raisch DW, Ezekowitz MD, Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators.
    N Engl J Med; 2005 May 05; 352(18):1861-72. PubMed ID: 15872201
    [Abstract] [Full Text] [Related]

  • 16. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B, Straumann E, Bertel O.
    Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188
    [Abstract] [Full Text] [Related]

  • 17. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone.
    Kapoor A, Kumar S, Singh RK, Pandey CM, Sinha N.
    J Heart Valve Dis; 2002 Nov 18; 11(6):802-9. PubMed ID: 12479281
    [Abstract] [Full Text] [Related]

  • 18. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.
    Kosior DA, Opolski G, Wozakowska-Kaplon B, Rabczenko D, Investigators of the HOT CAFE Polish Trial.
    Cardiology; 2005 Nov 18; 104(1):35-44. PubMed ID: 15942183
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2340-7. PubMed ID: 17161267
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH, van de Loo A, Baedeker F.
    J Am Coll Cardiol; 1995 Oct 05; 26(4):852-8. PubMed ID: 7560608
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.